The world's first intranasal Covid-19 vaccine was launched in India's New Delhi today.
A special campaign for administering the fourth Covid-19 vaccine dose starts today.
The government is going to launch a mass Covid vaccination campaign across the country from December 1 to 7 with a target to administer jabs, including booster doses, to 90 lakh people.
Moderna is suing Pfizer and its German partner BioNTech for patent infringement in the development of the first Covid-19 vaccine approved in the United States, alleging they copied technology that Moderna developed years before the pandemic.
The Covid-19 vaccination campaign for schoolchildren, aged 5-11 years, has started in city corporation areas countrywide today (August 25).
The Directorate General of Health Services (DGHS) will launch the Covid-19 inoculation campaign for children, aged 5-11 years, today.
The world's first intranasal Covid-19 vaccine was launched in India's New Delhi today.
A special campaign for administering the fourth Covid-19 vaccine dose starts today.
A special campaign for administering fourth Covid vaccine dose will start on December 20.
Administration of the fourth dose of Covid vaccine will begin on December 20 at seven vaccination centres in Dhaka.
The world's first intra-nasal Covid vaccine developed by India has got the approval from the country's Central Drugs Standard Control Organisation for restricted use.
People aged 60 years and above will receive their fourth dose of coronavirus vaccines, Health Minister Zahid Maleque said yesterday.
People aged 60 years and above will receive the fourth dose of Covid-19 vaccine, Health Minister Zahid Maleque said today.
The government is going to launch a mass Covid vaccination campaign across the country from December 1 to 7 with a target to administer jabs, including booster doses, to 90 lakh people.
The government will hold a special inoculation campaign against Covid-19 with booster doses across the country on December 1-7, Health Minister Zahid Maleque said today.
Adar Poonawalla, the chief executive officer of Serum Institute of India (SII), said on Thursday (October 20, 2022) that his company has stopped manufacturing Covid-19 vaccine Covishield since December last year due to lack of demand.